Loraz and Bradykinesia - a phase IV clinical study of FDA data
Summary:
Bradykinesia is reported as a side effect among people who take Loraz (lorazepam), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Sertraline, and have Parkinson's disease.
The phase IV clinical study analyzes which people have Bradykinesia when taking Loraz. It is created by eHealthMe based on reports of 161,700 people who have side effects when taking Loraz from the FDA, and is updated regularly.
What is Loraz?
Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,695 Loraz users. Check the latest studies of Loraz.
What is Bradykinesia?
Bradykinesia (decreased bodily movement. it is associated with basal ganglia diseases) is found to be associated with 429 drugs and 473 conditions by eHealthMe. Check the latest studies of Bradykinesia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
161,700 people reported to have side effects when taking Loraz.
Among them, 357 people (0.22%) have Bradykinesia.

Among these 357 people:
How long have people been on Loraz when they have Bradykinesia? *
What is the gender of people who have Bradykinesia when taking Loraz? *
What is the age of people who have Bradykinesia when taking Loraz? *
What are other drugs people take besides Loraz? *
What are other side effects people have besides Bradykinesia? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Loraz and have Bradykinesia?
- Check whether Bradykinesia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Loraz:
- Loraz (165,695 reports)
Bradykinesia treatments and more:
- Bradykinesia (6,795 reports)
How severe was Bradykinesia and when was it recovered:
Expand to all the drugs that have ingredients of lorazepam:
- Bradykinesia and drugs with ingredients of lorazepam (384 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Loraz:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Bradykinesia:
- Bradykinesia (429 drugs)
Browse all the conditions that are associated with Bradykinesia:
- Bradykinesia (473 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lorazepam (the active ingredients of Loraz) and Loraz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Imbruvica cause Pulmonary Mass? - 2 seconds ago
- Could Xeljanz cause Abdominal Rigidity? - 4 seconds ago
- Could Vitamin D cause Neck Mass? - 5 seconds ago
- Amaryl and Omeprazole drug interactions for women aged 40-49 - 6 seconds ago
- L-Tyrosine vs. Klonopin, side effect and effectiveness comparison - 7 seconds ago
- Traumatic Lung Injury and drugs of ingredients of alendronate sodium - 13 seconds ago
- Peripheral Vascular Disorder and drugs of ingredients of sulfamethoxazole; trimethoprim - 15 seconds ago
- Arava and Low Blood Platelet Count for Men aged 50-59 - 16 seconds ago
- Arava and Low Platelet Count for Men aged 50-59 - 17 seconds ago
- Arava and Platelet Count Decreased for Men aged 50-59 - 17 seconds ago